BAK1 Produits
(BCL2-Antagonist/killer 1 (BAK1))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories BAK1 en vedette
BAK1 Anticorps
High quality antibodies with extensive validation data.
BAK1 Kits ELISA
Reliable ELISA kits for a wide range of species.
BAK1 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
BAK1 recommandé Anticorps
- (6)
- (8)
- (2)
- (10)
BAK1 recommandé Kits ELISA
- (1)
- (1)
- (1)
BAK1 recommandé Protéines
- (1)
- (1)
- (1)
Dernières publications sur nos produits BAK1
: "YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis." dans: The Journal of pathology, (2019) (PubMed).: "Copper induces oxidative stress and apoptosis through mitochondria-mediated pathway in chicken hepatocytes." dans: Toxicology in vitro : an international journal published in association with BIBRA, Vol. 54, pp. 310-316, (2019) (PubMed).
: "MicroRNA-29c Correlates with Neuroprotection Induced by FNS by Targeting Both Birc2 and Bak1 in Rat Brain after Stroke." dans: CNS neuroscience & therapeutics, Vol. 21, Issue 6, pp. 496-503, (2016) (PubMed).
: "Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability." dans: Molecular neurobiology, (2015) (PubMed).
: "Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity." dans: Cancer letters, Vol. 364, Issue 2, pp. 125-34, (2015) (PubMed).
: "Notch4 Signaling Confers Susceptibility to TRAIL-Induced Apoptosis in Breast Cancer Cells." dans: Journal of cellular biochemistry, Vol. 116, Issue 7, pp. 1371-80, (2015) (PubMed).
: "Regulation of cell transformation by Rb-controlled redox homeostasis." dans: PLoS ONE, Vol. 9, Issue 7, pp. e102582, (2014) (PubMed).
: "The C-terminal domain (CTD) in linker histones antagonizes anti-apoptotic proteins to modulate apoptotic outcomes at the mitochondrion." dans: Cell death & disease, Vol. 5, pp. e1058, (2014) (PubMed).
: "Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy." dans: Cancer research, Vol. 73, Issue 2, pp. 519-28, (2013) (PubMed).
: "Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells." dans: Cell death and differentiation, Vol. 19, Issue 12, pp. 1928-38, (2012) (PubMed).
Synonymes et noms alternatifs relatifs à BAK1
BCL2 antagonist/killer 1 (BAK1), BCL2-antagonist/killer 1 (Bak1), BCL2 antagonist/killer 1 (Bak1), BCL2 antagonist/killer 1 L homeolog (bak1.L), BAK, Bak, bak, BAK-LIKE, Bak1, bak1, BCL2L7, CDN1, N-Bak, N-BAK1Protein level used designations for BAK1
- BCL2-like 7 protein
- apoptosis regulator BAK
- bcl-2 homologous antagonist/killer
- bcl-2-like protein 7
- bcl2-L-7
- pro-apoptotic protein BAK
- Bcl2 homologous antagonist/killer
- Bcl-2-like 7
- BCL2 antagonist/killer 1 L homeolog